Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Cassier

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
American Journal of Infection Control|May 29, 2012
Totally implantable central venous access port infections in patients with digestive cancer: incidence and risk factorsAbdoulaye Touré, Philippe Vanhems, Catherine Lombard-Bohas, et al.
Clinical Pharmacology : Advances and Applications|December 4, 2012
Pazopanib for the treatment of soft-tissue sarcomaPierre Heudel, Philippe Cassier, Olfa Derbel, et al.
EJNMMI Physics|January 20, 2017
3D absorbed dose distribution estimated by Monte Carlo simulation in radionuclide therapy with a monoclonal antibody targeting synovial sarcomaDavid Sarrut, Jean-Noël Badel, Adrien Halty, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 17, 2014
Assessing the multimodal management of advanced solitary fibrous tumors of the pleura in a routine practice settingOlivier Bylicki, Damien Rouvière, Philippe Cassier, et al.
BMC Cancer|October 27, 2015
KIT exon 10 variant (c.1621 A > C) single nucleotide polymorphism as predictor of GIST patient outcomeMehdi Brahmi, Laurent Alberti, Armelle Dufresne, et al.
BMC Cancer|August 17, 2017
Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumorsSylvie Négrier, David Pérol, Rastislav Bahleda, et al.
Cancer Chemotherapy and Pharmacology|April 8, 2014
Pharmacokinetics of pazopanib administered in combination with bevacizumabDiane-Charlotte Imbs, Sylvie Négrier, Philippe Cassier, et al.
The Oncologist|March 24, 2022
Phase I Study of JNJ-74699157 in Patients with Advanced Solid Tumors Harboring the KRAS G12C MutationJudy Wang, Patricia Martin-Romano, Philippe Cassier, et al.
Clinical Sarcoma Research|September 7, 2012
Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib: an active agent only in non progressive patientsFlorence Duffaud, Caroline Even, Isabelle Ray-Coquard, et al.
Frontiers in Oncology|November 28, 2022
Expanding the molecular spectrum of tenosynovial giant cell tumorsThibault Gauduchon, Helene Vanacker, Daniel Pissaloux, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
American Journal of Infection Control|May 29, 2012
Totally implantable central venous access port infections in patients with digestive cancer: incidence and risk factorsAbdoulaye Touré, Philippe Vanhems, Catherine Lombard-Bohas, et al.
Clinical Pharmacology : Advances and Applications|December 4, 2012
Pazopanib for the treatment of soft-tissue sarcomaPierre Heudel, Philippe Cassier, Olfa Derbel, et al.
EJNMMI Physics|January 20, 2017
3D absorbed dose distribution estimated by Monte Carlo simulation in radionuclide therapy with a monoclonal antibody targeting synovial sarcomaDavid Sarrut, Jean-Noël Badel, Adrien Halty, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 17, 2014
Assessing the multimodal management of advanced solitary fibrous tumors of the pleura in a routine practice settingOlivier Bylicki, Damien Rouvière, Philippe Cassier, et al.
BMC Cancer|October 27, 2015
KIT exon 10 variant (c.1621 A > C) single nucleotide polymorphism as predictor of GIST patient outcomeMehdi Brahmi, Laurent Alberti, Armelle Dufresne, et al.
BMC Cancer|August 17, 2017
Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumorsSylvie Négrier, David Pérol, Rastislav Bahleda, et al.
Cancer Chemotherapy and Pharmacology|April 8, 2014
Pharmacokinetics of pazopanib administered in combination with bevacizumabDiane-Charlotte Imbs, Sylvie Négrier, Philippe Cassier, et al.
The Oncologist|March 24, 2022
Phase I Study of JNJ-74699157 in Patients with Advanced Solid Tumors Harboring the KRAS G12C MutationJudy Wang, Patricia Martin-Romano, Philippe Cassier, et al.
Clinical Sarcoma Research|September 7, 2012
Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib: an active agent only in non progressive patientsFlorence Duffaud, Caroline Even, Isabelle Ray-Coquard, et al.
Frontiers in Oncology|November 28, 2022
Expanding the molecular spectrum of tenosynovial giant cell tumorsThibault Gauduchon, Helene Vanacker, Daniel Pissaloux, et al.
Pageof 6